Literature DB >> 8457221

Cancer in systemic sclerosis.

M Abu-Shakra1, F Guillemin, P Lee.   

Abstract

OBJECTIVE: To determine whether the frequency of cancer is increased among patients with systemic sclerosis (SSc).
METHODS: A retrospective chart review of 248 patients who were followed up prospectively was conducted.
RESULTS: Cancers developed in 18 patients (7.3%) during 2,001 patient-years at risk. The most frequent types were cancers of the lung (7 patients) and breast (5 patients). Older age at diagnosis of SSc was a significant risk factor for cancer. Lung cancer was associated with the presence of pulmonary fibrosis. The age-standardized incidence rate for all cancers (7.9/1,000) was 2.1 times the overall rate in the Ontario population (P < 0.0001).
CONCLUSION: The frequency of cancer is increased in patients with SSc.

Entities:  

Mesh:

Year:  1993        PMID: 8457221     DOI: 10.1002/art.1780360405

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  46 in total

Review 1.  Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models.

Authors:  Aya M Westbrook; Akos Szakmary; Robert H Schiestl
Journal:  Mutat Res       Date:  2010-03-16       Impact factor: 2.433

2.  Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies.

Authors:  Ami A Shah; Antony Rosen; Laura Hummers; Fredrick Wigley; Livia Casciola-Rosen
Journal:  Arthritis Rheum       Date:  2010-09

Review 3.  Cancer and scleroderma: a paraneoplastic disease with implications for malignancy screening.

Authors:  Ami A Shah; Livia Casciola-Rosen
Journal:  Curr Opin Rheumatol       Date:  2015-11       Impact factor: 5.006

4.  Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival.

Authors:  Abdulla Watad; Dennis McGonagle; Nicola L Bragazzi; Shmuel Tiosano; Doron Comaneshter; Yehuda Shoenfeld; Arnon D Cohen; Howard Amital
Journal:  Oncoimmunology       Date:  2019-03-24       Impact factor: 8.110

Review 5.  Management of Esophageal Squamous Cell Carcinoma with Definitive Chemoradiotherapy in a Patient with Scleroderma: Case Report and Review of the Literature.

Authors:  David P Horowitz; Balazs Halmos; John Poneros; Joshua Sonett; Helen Remotti; Ryan J Burri
Journal:  J Gastrointest Cancer       Date:  2012-09

Review 6.  Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications.

Authors:  Ami A Shah; Antony Rosen
Journal:  Curr Opin Rheumatol       Date:  2011-11       Impact factor: 5.006

Review 7.  Cancer and Scleroderma.

Authors:  Emma Weeding; Livia Casciola-Rosen; Ami A Shah
Journal:  Rheum Dis Clin North Am       Date:  2020-06-10       Impact factor: 2.670

8.  Post-Irradiation Morphea: Case report and review of the literature.

Authors:  Ammar Alhathlool; Rüdiger Hein; Christian Andres; Johannes Ring; Bernadette Eberlein
Journal:  J Dermatol Case Rep       Date:  2012-09-28

9.  Behcet's disease associated with malignancy in Korea: a single center experience.

Authors:  Joong Kyong Ahn; Ji Min Oh; Jaejoon Lee; Eun-Mi Koh; Hoon-Suk Cha
Journal:  Rheumatol Int       Date:  2009-12-17       Impact factor: 2.631

10.  Risk of cancer in patients with scleroderma: a population based cohort study.

Authors:  C L Hill; A-M Nguyen; D Roder; P Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.